Form EFFECT Moleculin Biotech, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 7, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen F
- OLD REPUBLIC DECLARES THIRD QUARTER REGULAR DIVIDEND OF 31.5 CENTS PER SHARE
- Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
